within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AX18_Letermovir;

model Letermovir_1
  extends Pharmacolibrary.Drugs.ATC.J.J05AX18_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AX18_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Letermovir is an antiviral medication approved for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). It works as a CMV DNA terminase complex inhibitor and is currently approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model in healthy volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>Prohn, M, et al., &amp; Cho, CR (2021). Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients. <i>CPT: pharmacometrics &amp; systems pharmacology</i> 10(3) 255–267. DOI:<a href=&quot;https://doi.org/10.1002/psp4.12593&quot;>10.1002/psp4.12593</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33440077/&quot;>https://pubmed.ncbi.nlm.nih.gov/33440077</a></p></li><li><p>Groll, AH, et al., &amp; Badshah, C (2024). Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients. <i>The Pediatric infectious disease journal</i> 43(3) 203–208. DOI:<a href=&quot;https://doi.org/10.1097/INF.0000000000004208&quot;>10.1097/INF.0000000000004208</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38241643/&quot;>https://pubmed.ncbi.nlm.nih.gov/38241643</a></p></li><li><p>Kropeit, D, et al., &amp; Rübsamen-Schaeff, H (2022). Pharmacokinetics and Safety of Letermovir and Midazolam Coadministration in Healthy Subjects. <i>Clinical pharmacology in drug development</i> 11(1) 16–24. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1027&quot;>10.1002/cpdd.1027</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34714967/&quot;>https://pubmed.ncbi.nlm.nih.gov/34714967</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Letermovir_1;
